Omar A Khan

US Patent:

8196097, Jun 5, 2012

Filed:

Mar 2, 2007

Appl. No.:

11/713412

Inventors:

Satish Sampath - Bangalore, IN
Carolyn Au - Pacifica CA, US
Omar Khan - San Francisco CA, US
Andrew M. Scherkus - Oakville, CA

Assignee:

Google Inc. - Mountain View CA

International Classification:

G06F 9/44

US Classification:

717110, 717111, 717115, 719329

Abstract:

One embodiment of the present invention provides a system for extending a gadget. During operation, the system initially executes a gadget extension which extends a host gadget. In doing so, the system obtains from the gadget extension a specifier for the host gadget and a specifier for an interface. Next, the system establishes a communication interface between the gadget extension and the host gadget through the interface. Finally, the system uses functionality of the host gadget within the gadget extension via communication through the communication interface.

US Patent:

20070174384, Jul 26, 2007

Filed:

Jan 25, 2006

Appl. No.:

11/339322

Inventors:

John Abd-El-Malek - Sunnyvale CA, US
Omar Khan - San Francisco CA, US

International Classification:

G06F 15/16

US Classification:

709203000

Abstract:

A computer implemented method is described. The method includes receiving an event associated with a user selection of an item displayed by a sidebar application running on a first client. The sidebar application being an application that is configurable to aggregate multiple types of items from sources external to the sidebar application. The method also includes receiving an identifier associated with an external client, the external client being different from the first client, and initiating, using the sidebar application, transmission of the item to the external client.

US Patent:

20220235380, Jul 28, 2022

Filed:

Mar 8, 2022

Appl. No.:

17/689837

Inventors:

- South San Francisco CA, US
Michelle Nguyen - San Francisco CA, US
Anzhi Yao - South San Francisco CA, US
Stephen Santoro - Daly City CA, US
Aaron Cooper - Berkeley CA, US
John Gagnon - San Francisco CA, US
Adam Litterman - San Francisco CA, US
Omar Khan - Philadelphia PA, US
Natalie Bezman - Foster City CA, US

International Classification:

C12N 15/90
C07K 14/725
C07K 14/705
C12N 9/22
C12N 15/85
A61P 35/00

Abstract:

Provided herein are recombinant nucleic acids encoding chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX. Also provided are systems of chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX, cells expressing such proteins and shRNA, and methods of use thereof.

US Patent:

20220211759, Jul 7, 2022

Filed:

May 1, 2020

Appl. No.:

17/607612

Inventors:

- Philadelphia PA, US
Omar KHAN - San Francisco CA, US
Josephine GILES - Philadelphia PA, US

International Classification:

A61K 35/17
C12N 5/0783
C12N 15/11
C12N 9/22
A61P 31/04

Abstract:

The present invention provides methods of preventing, reducing or reversing T cell exhaustion in a patient having a disease. The present invention also provides methods for treating a disease in a patient having the disease. The present invention also provides an engineered T cell, and uses thereof.

US Patent:

20210330600, Oct 28, 2021

Filed:

Dec 19, 2019

Appl. No.:

17/414193

Inventors:

- Cambridge MA, US
Jasdave CHAHAL - Melrose MA, US
Justine McPARTLAN - Chelsea MA, US
Omar KHAN - Woburn MA, US
Karl RUPING - Cambridge MA, US

Assignee:

TIBA BIOTECH LLC - Cambridge MA

International Classification:

A61K 9/51
A61K 39/39
A61K 49/18
A61K 49/12
A61K 38/17

Abstract:

Nanoparticle compositions for delivery of nucleic acids to subjects including modified dendrimers comprising cores, one or more of homogeneous or heterogeneous intermediate and terminal layers, and therapeutic or immunogenic nucleic acid agents enclosed within nanop article compositions are described. Methods for treating or preventing diseases or conditions in a subject by administering the nanoparticle compositions that provide immune responses and synergistic therapeutic or preventive effects are provided.

US Patent:

20210014308, Jan 14, 2021

Filed:

Jul 9, 2019

Appl. No.:

16/506821

Inventors:

- Sacramento CA, US
Omar Khan - San Ramon CA, US
Jonathan Egan Salcedo - San Francisco CA, US

Assignee:

Rhombus Systems - Sacramento CA

International Classification:

H04L 29/08
G06T 7/70
G06K 9/00
G06T 7/00
H04N 5/247
G08B 21/18
H04W 76/19
H04L 9/32

Abstract:

A sensor monitoring system includes a plurality of image capture devices. Each image capture device includes one or more sensors to detect image data representing an environment about the image capture device, communications circuitry to receive sensor data from a sensor device and remote sensor data including at least one of a second image of the sensor or second position data regarding the sensor device, and processing circuitry to validate the sensor device based on the sensor data, determine first position data regarding the sensor device based on at least one of the first network connection or the remote sensor data, determine that the sensor device is in an image capture range based on the first position data, retrieve one or more images of the sensor device, and generate an alert based on the first position data.

US Patent:

20180353435, Dec 13, 2018

Filed:

Jun 7, 2018

Appl. No.:

16/002965

Inventors:

- Cambridge MA, US
Amanda Chung - Malden MA, US
Pedro P. G. Guimaraes - Revere MA, US
Omar F. Khan - Cambridge MA, US
Robert S. Langer - Newton MA, US
Daniel Griffith Anderson - Framingham MA, US

International Classification:

A61K 9/51
C12N 15/113

Abstract:

The present invention provides compositions (e.g., nanoparticles) comprising a conjugated polyethyleneimine (PEI) polymer (a “conjugated lipomer”), or a pharmaceutically acceptable salt thereof, and a lipid-PEG conjugate, wherein the conjugated lipomer of Formula (I) contains one or more groups of the formula (iii). Compositions of the invention are useful for the delivery of active agents, for example, for the treatment of disease.